Germany – Conclusion not excluding drug discount agreement.according to Section 130a Paragraph 8 SGB V through an open house model for the active ingredient certolizumab pegol (ATC code according to WHO: L04AB05)
By: Public Purchasing Data Service (responsible for the Procurement Office of the BMI)📍 GermanyOpen
Key Information
| Reference | GB-728085-2026 |
|---|
| Deadline | Jun 30, 2028 12:00 AM |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Germany |
|---|
| Address | Bonn, 53119, Germany |
|---|
| Published | Oct 21, 2026 |
|---|
Description
2. Procedure2.1.procedureTitle: Conclusion not excluding drug discount agreement.according to Section 130a Paragraph 8 SGB V through an open house model for the active ingredient certolizumab pegol (A...
Full details are available after unlocking this tender.